How to Subscribe
MLS & MLT Comprehensive CE Package
Includes 154 CE courses, most popular
$95Add to cart
Pick Your Courses
Up to 8 CE hours
$50Add to cart
Individual course$20Add to cart
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Acute Viral Hepatitis Panel. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Acute Viral Hepatitis Panel (online CE course)

Hepatitis testing encompasses two types of laboratory assays; immunoassays and nucleic acid amplification testing (NAAT). A detailed description of the many different types of immunoassays and amplification testing systems used by clinical laboratories is outside the scope of this short course. Instead, we will briefly discuss two specific types of immunoassay that are commonly used in viral hepatitis testing, the EIA and CIA.
Immunoassays are laboratory detection tests that employ antibodies to capture and detect target antigens within specimens. Conversely, they can also use antigens to capture a specific antibody that is present in the specimen and then quantitates the amount of antibody present. Once the specific binding has occurred, wash steps ensue and remove excess reagents. A biochemical reporter system (light production, a color change, or even the presence of radioactivity) can then be used to quantify the amount of analyte present in the specimen.
NAAT uses the polymerase chain reaction (PCR) sequence to amplify a specific DNA sequence that can then be detected using detection probes. In the case of RNA viruses, reverse-transcriptase PCR (RT-PCR) is used to first amplify and then detect and quantify viral RNA. In the context of hepatitis, NAAT is used primarily for the quantitation of HCV RNA. Monitoring HCV viral load (the amount of viral RNA in the patient's serum) is a vital tool in the treatment of chronic HCV infection.